We investigated the feasibility of myocardial contrast echocardiography (MCE) to evaluate regional perfusion after bone marrow cell transplantation. BACKGROUND The myocardial microvessels improved by cell transplantation are too small to visualize with conventional angiography.
Several researches reported that bone marrow cell transplantation into the heart induced angiogenesis (1) (2) (3) (4) . Assessment of myocardial perfusion after therapy is important. For a long time, vascular density on histologic study has been used to evaluate the therapeutic effectiveness of cell transplantation on myocardial infarction (MI) in experimental studies (5) . However, it is invasive and difficult to perform a biopsy of the targeted area in clinical examinations.
Microvessels induced by bone marrow cell transplantation are too small (Ͻ50 m) to visualize using conventional angiography (2, 6) . Although previous studies have found bone marrow cell transplantation to be effective, concrete and objective evidence for this therapy in daily clinical examinations has not been demonstrated.
Myocardial contrast echocardiography (MCE) is a noninvasive and inexpensive tool to evaluate myocardial perfusion in the microvasculature (7, 8) , and it can be performed even at the bedside. The purposes of this study were to verify the feasibility of MCE and to evaluate angiogenesis after bone marrow cell transplantation in the chronic ischemic heart of pigs. using a ventilation mask with 1% to 3% isoflurane, oxygen at 10 l/min, and ketamine hydrochloride (12 to 15 mg/kg intravenously). The animals were intubated using a cuffed endotracheal tube and were ventilated with 50% oxygen to maintain end-tidal CO 2 between 30 and 35 mm Hg. Anesthesia was maintained with 0.5% to 1.0% isoflurane in oxygen at a flow rate of 3 to 4 l/min and fraction of inspired oxygen (FIO 2 ) at 50%. Electrocardiography was used to monitor the heart rate, rhythm, and ST-segment changes during the surgical procedure.
Under general anesthesia, a left lateral thoracotomy was performed. The left anterior descending coronary artery was double-ligated with 2-0 silk (2) . Ventricular fibrillation and tachycardia were treated with xylocaine and a defibrillator. After the lungs were adequately inflated, the pericardium was closed using 4-0 prolene sutures, and the chest was closed with #1 prolene. A 10-ml volume of sternal bone marrow was aspirated for culture. The pigs were weaned from anesthetics, extubated, and kept warm in a pen. The surgical team administrated analgesic to the pigs, if needed.
By one month after MI, 5 of the 14 pigs had died. The nine pigs that survived were randomized as follows. Six of the nine pigs were assigned to a cell transplantation group whose subsets were bone marrow mononuclear cells (BMMNCs) (n ϭ 3) and bone marrow stromal cells (BMSCs) (n ϭ 3). The other three pigs received saline (control group, n ϭ 3) (9). Cell preparation. BONE MARROW MONONUCLEAR CELLS. In the BMMNC subset, at one month after MI, immediately before cell transplantation, 50 to 100 ml of fresh bone marrow was aspirated and loaded onto Lymphoprep (AXIS-SHIELD PoC AS, Oslo, Norway) (2). The solution was centrifuged at 800g at 4°C for 20 min. A white layer was aspirated and washed with phosphate-buffered saline twice, and 1 ϫ 10 8 cells/ml was created.
BONE MARROW STROMAL CELLS .
A 10-ml volume of bone marrow was aspirated from the sternum on the same day as MI and then cultured in cell culture medium: Iscove's modified Dulbecco's medium with 10% fetal bovine serum, penicillin G (100 U/ml), streptomycin (100 g/ml), and amphotericin B (0.2 g/ml) (9). The cells were incubated with 95% air and 5% CO 2 at 37°C for one month. The cultured BMSCs were dissociated from the culture dish with 0.05% trypsin in phosphate-buffered saline, collected, and centrifuged at 570g. The cells were then suspended to obtain a concentration of 1 ϫ 10 8 cells in 1.0 ml. This suspension was injected in the same pig as registered in this BMSC subset.
Under general anesthesia, we performed bone marrow cell transplantation after a median sternotomy. We longitudinally opened the pericardium, exposing the heart to visualize the left anterior descending and diagonal arteries, so that we could recognize where the anterior wall was. Bone marrow cells were autologously injected using a 27-gauge needle with a 1-ml syringe. We made sure that the tip of the needle was not intracavitary with negative pressure when using the syringe and then injected each 0.1-ml cell solution of 10 8 cells/ml at each of the 10 sites on the left ventricular anterior free wall at the mid-ventricle. Myocardial contrast echocardiography. A specialist in MCE performed MCE at two stages: one month after infarction (before cell transplantation) and one month after cell transplantation. A SONOS 5500 system (Philips, Andover, Massachusetts) was used (2,10). All imaging was performed at the mid-papillary muscle level of the left ventricle, under a closed-chest condition. The MCE imaging was performed in the second harmonic mode, in which ultrasound was transmitted at 1.8 MHz and received at 3.6 MHz. The mechanical index was set at 1.4 to 1.6. The maximal dynamic range was 60 dB. As a venous contrast agent, we used the second-generation microbubbles called YM-454 (Definity, Bristol-Myers Squibb Medical Imaging Inc., North Billerica, Massachusetts) (8) . They are composed of a bilayer phospholipid shell and perfluoropropane. The mean size of gas-filled liposomes is about 2.5 m. This agent was injected intravenously at a rate of 100 l/min. We used the intermittent mode and the multiframe trigger method in MCE, and we set the trigger point at the end-systolic phase every 4 beats in this study.
Data were recorded on 1.25-cm videotape with an S-VHS recorder and on a 5-inch magnetic optical disk (11, 12) and analyzed off-line using QuantiCon (Echotech 3D Imaging Systems, GmbH, Hallbergmoos, Germany). We put the region of interest on targeted areas and calculated their myocardial intensities. We subtracted the intensity of phase B from that of phase A at a target. Phase A occurred when the microbubbles sufficiently filled the myocardium, and phase B occurred when about 80% of microbubbles were destroyed by a series of three frames of the ultrasound beam within the end-systolic phase. We regarded this subtracted intensity as myocardial contrast intensity (MCI) for analysis. The acoustic unit (AU) was determined using the Acoustic densitometry software package (Philips), which displays intensities in dB (13) . Acoustic densitometry provides an integrated on-line capability to measure, display, and analyze the average acoustic image intensity. Off-line densitometric systems that offer a "digital" solution for data storage using magnetic/optimal disk media are also plagued with the problem of nonlinearity in the image data (13 . We put the region of interest on four different target areas for measurement of intensity: anteroseptum (nontransplanted infarct area), anterior wall (transplanted infarct area), septum (border area), and lateral wall (normal area). At these four target areas, MCI and capillary density (CD) were measured and compared. Wall thickness. To evaluate wall motion, we measured the wall thickness of the systolic and diastolic phases at the anteroseptum (nontransplanted infarct area), anterior wall (transplanted infarct area), and lateral wall (normal area). We calculated the wall thickness (systole/diastole) ratio and assessed the regional wall motion. Histologic studies (CD). At one month after cell transplantation, we performed MCE to assess MCI, after which the heart was arrested with potassium chloride and excised for histologic study. The coronary arteries were then perfused with 10% formaldehyde (100 ml), and the heart was immersed in the formaldehyde for 20 days.
After fixation, a cube (5 ϫ 10 ϫ 10 mm) of tissue from each site, where MCE was evaluated, was embedded in paraffin and cut into 6-m sections for staining with hematoxylin-eosin, as described in the manufacturer's specifications (Sigma Chemical Co., St. Louis, Missouri), and von Willebrand factor-related antigen (14) . A pathologist and an orthopedist investigated bone formation and tumorigenic formation. An observer blinded to the treatment groups and subsets determined the CD of the anteroseptum (nontransplanted infarct area), anterior wall (transplanted infarct area), septum (border area), and lateral wall (normal area). Five fields of each section were randomly selected, and the CD was averaged and expressed as the number of blood vessels per mm 2 (15) . Statistical methods. Data are expressed as the mean value Ϯ SD. Interstage comparisons in each group and intrastage differences between two groups were confirmed using the Mann-Whitney U test. Analysis System software (Statcel, OMS Publishing Company, Tokorozawa, Saitama, Japan) was used for these two analyses. Correlations were performed using logarithmic or linear regression analysis. Differences were considered significant at p Ͻ 0.05.
RESULTS
There was no critical arrhythmia before, during, or after cell transplantation. Heart rate and blood pressure were stable during transplantation. The nine pigs that survived for one month after MI completed the whole procedure. Capillary density and MCI of normal, nontransplanted infarct, and transplanted infarct areas. The CD of the normal area was 2.12 Ϯ 0.58 (ϫ10 3 /mm 2 ) and that of the nontransplanted infarct area was 0.46 Ϯ 0.19 (ϫ10 3 /mm 2 ) ( Table 1 ). The MCI of the normal area was 0.54 Ϯ 0.19 and that of the nontransplanted infarct area was 0.13 Ϯ 0.02 (Table 2 ). Both the CD and MCI of the normal area were significantly higher than those of the nontransplanted infarct area (p ϭ 0.00035 and p ϭ 0.00035, respectively).
On the transplanted infarct area, the CD of the transplant group (including the BMMNC and BMSC subsets) was 1.53 Ϯ 0.63 (ϫ10 3 /mm 2 ) and that of the control group was 0.27 Ϯ 0.07 (ϫ10 3 /mm 2 ) ( Table 1) . On the same area, the MCI of the transplant group was 0.38 Ϯ 0.20 and that of the control group was 0.12 Ϯ 0.02 ( Table 2) .
The CD and MCI of the transplanted infarct area in the transplant group were significantly higher than those of the same area in the control group (p ϭ 0.020 and p ϭ 0.028, respectively). Wall thickness ratio (systole/diastole) of normal, nontransplanted infarct, and transplanted infarct areas. The wall thickness systolic/diastolic ratio at the normal area was significantly larger than that at the nontransplanted infarct area (1.50 Ϯ 0.18 and 1.07 Ϯ 0.09, respectively; p ϭ 0.0003) ( Table 3 ). In the cell transplant group, the wall thickness systolic/diastolic ratio at the transplanted infarct area was significantly larger than that at the nontransplanted infarct area (1.48 Ϯ 0.15 and 1.08 Ϯ 0.1, respectively; p ϭ 0.004), although there was no difference in the control group. Further, when we compared the systolic/diastolic ratio between the cell transplant group and control group at the transplanted infarct area, the ratio in the transplant group was significantly larger than that in control group (1.48 Ϯ 0.15 and 1 Ϯ 0, respectively; p ϭ 0.02) ( Table 3) .
Comparison of CD in nontransplanted and transplanted infarct areas. The histologic findings of the section stained for von Willebrand factor are shown in Figure 1 . In both the BMMNC and BMSC subsets, the anteroseptum (nontransplanted infarct area) contained very few capillaries ( Fig. 1  [1a and 2a] ). In contrast, the anterior wall (transplanted infarct area) contained more capillaries than the anteroseptum (Figs. 1 [1b and 2b] ). The size of the capillaries at the transplanted infarct area ranged from 5 to 20 m, which varied more than that of the normal area (10 to 20 m). Bone formation or tumorigenic formation was not observed at the transplanted area in any pig. In the cell transplant group, the CD of the anterior wall was significantly larger than that of the anteroseptum (p ϭ 0.0081) ( Fig. 2A) (BMMNC subset, p ϭ 0.025; BMSC subset, p ϭ 0.025) (Fig. 2B) . In the control group, the CD of both the anterior wall and anteroseptum was low, and there was no significant Figure 1 . Capillary formation at the anteroseptum and anterior wall. Number 1 represents the bone marrow mononuclear cell (BMMNC) subset; number 2 represents the bone marrow stromal cell (BMSC) subset; and number 3 represents the control group (magnification ϫ200). The top row (1a, 2a, 3a) shows the findings of the anteroseptum (nontransplanted infarct area), and bottom row (1b, 2b, 3b) shows the findings of the anterior wall (transplanted infarct area). In the BMMNC and BMSC subsets, the anterior wall (1b, 2b) contained more capillaries than the anteroseptum (1a, 2a). In contrast, in the control group, both the anteroseptum (3a) and anterior wall (3b) contained very few capillaries. difference between the two areas (p ϭ NS) (Fig. 2A) . The CD of the anteroseptum in the BMMNC subset was larger than that of the other subset or group (p ϭ 0.027). Relationship between MCI and CD. Figure 3 shows typical graphs of the four target areas at one month after BMMNC transplantation. The MCI of the anterior wall (transplanted infarct area) was higher than that of the anteroseptum (nontransplanted infarct area). The MCI and CD of four target areas at the same stage were plotted (Fig. 4) .
The MCI and histologic CD correlated well based on data derived from four areas of all pigs. When MCI was analyzed by decibel, MCI and CD were correlated logarithmically (dB ϭ 7.32Log[CD] ϩ 5.89; r ϭ 0.90, p Ͻ 0.001) (Fig. 4A ). There was a significant linear relation between MCI analyzed by AU 2 and CD (MCI [AU 2 ] ϭ 0.23 CD ϩ 0.01; r ϭ 0.92, p Ͻ 0.001) (Fig. 4B) . Time course of MCI. In the control and cell transplant groups, there was the same time trend of MCI at the anteroseptum (nontransplanted infarct area), which slightly decreased (p ϭ NS) (Fig. 5A) . In contrast, the MCI of the anterior wall (transplanted infarct area) significantly increased in the cell transplant group (p ϭ 0.018), although it did not change in the control group (p ϭ NS) (Fig. 5B) .
DISCUSSION
The importance of this study is to establish a method to follow the effect of bone marrow cell transplantation not only in experimental studies but also in clinical examinations. Therefore, we performed MCE using Definity as the contrast agent and a commercially available ultrasound machine, based on the hypothesis that MCE would be a useful tool to assess the microcirculation after cell transplantation.
This study demonstrated that: 1) MCI measured by MCE was closely correlated with CD; 2) bone marrow cell transplantation increased blood perfusion at the infarct area; and 3) bone marrow cell transplantation into the heart was performed safely. Relationship between MCI and CD for assessment of myocardial perfusion. The relationship between MCI and CD showed a strong correlation. This result indicates that MCE is as useful as CD for evaluating angiogenesis. In previous experimental studies, CD or microsphere analysis Figure 3 . The myocardial contrast intensity (MCI) of the bone marrow mononuclear cell subset at one month after cell transplantation. The four graphs enable us to quantify MCI and to recognize the differences in the anteroseptum, anterior wall, septum, and lateral wall. The MCI in the anterior wall was higher than that in the anteroseptum.
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was generally used to assess angiogenesis (8, 16) . However, in clinical examinations, we cannot use these two methods. In contrast, MCE is a noninvasive and repeatable method to evaluate angiogenesis induced by bone marrow cell transplantation to the heart for clinical application. The microsphere method reflects functional myocardial perfusion. There are several reports stating that MCI using MCE reflects myocardial perfusion using the microsphere method (11, 17) . Therefore, MCI reflects functional myocardial perfusion.
Recently, it was reported that MCI evaluated by AU 2 is proportional to the concentration of microbubbles (13) . In this study, we proved that MCI evaluated by AU 2 is proportional to CD. This result indicates that the new microvessels created by bone marrow cell transplantation were functional. Importance of angiogenesis by bone marrow cell transplantation. Bone marrow cell transplantation (BMMNCs and BMSCs) induced angiogenesis in the transplanted area, as proved by CD and MCI. The angiogenesis induced by bone marrow cell transplantation may make the residual cardiac muscle and transplant cells survive, which may contribute to improvement of contraction (1).
The BMMNC subset. The BMMNCs contain various kinds of cells, such as hematopoietic cells, fibroblasts, myogenic cells, and endothelial cells, and they can work beneficially in the ischemic myocardium (12) . This study was consistent with our previous result (1). We observed angiogenesis, as described earlier, and did not see any bone formation. The BMMNCs have several advantages. Special facilities are not required because we can process them fresh by a clinically established protocol. This procedure is simple and can be performed safely. The BMSC subset. The BMSCs were cultured by Caplan's method, as previously reported (9, 18) . The BMSCs can be isolated from the other cells in marrow by their tendency to adhere to the culture dish. Stromal cells were a heterogeneous population (1). Our study suggested that the BMSCs could include stem cells differentiating into endothelial cells due to an increase in CD and improvement of myocardial perfusion.
The potential mechanisms inducing angiogenesis after endothelial cell transplantation are formation of blood vessels by transplanted endothelial cells and stimulation of angiogenesis by growth factors such as vascular endothelial growth factor, beta-fibroblast growth factor, and insulinlike growth factor-1 (2), expressed or stimulated by transplanted endothelial cells (15) .
The BMSCs can be cultured from only 10 ml of bone marrow; however, it takes time to expand and requires culture facilities satisfying good manufacturing practice for clinical applications. Effects of BMMNC and BMSC transplantation. The increases in CD and MCI after cell transplantation were recognized in both the BMMNCs and BMSCs. The BMSCs stimulated angiogenesis as fresh bone marrow cells (BMMNCs), as in our previous rat study (1) . The significant increases in CD and MCI at the transplanted infarct area indicated that bone marrow cell transplantation improved regional perfusion where cells were injected in both BMMNC and BMSC subsets. Wall motion after cell transplantation. In the cell transplant group, the regional wall motion of the transplanted infarct area was significantly improved after cell transplantation. This result indicates that improvement of perfusion after bone marrow cell transplantation is reflected in regional wall motion where bone marrow cells are transplanted. Follow-up MCE after cell transplantation. The MCI using MCE enabled us to assess the effects of this therapy not only by comparing the transplanted infarct area with the nontransplanted infarct area, but also by comparing the transplanted infarct area before and after cell transplantation; therefore, it is useful for follow-up after this therapy.
Bone marrow cell transplantation for clinical application.
Bone marrow cell transplantation was performed safely in our study. During the acute phase (perioperative period), there were no detrimental effects such as hypotension, arrhythmia, or hypoxemia. During the subchronic phase, there was no critical arrhythmia. There was no ectopic differentiation (bone formation) or tumorigenic formation at the transplant sites. From the point of view of clinical application, we regarded both the BMMNC and BMSC transplantations as feasible. Study limitations. The sample size of this study is low at the subset level. The bone marrow cell transplantation group was composed of BMMNC and BMSC subsets, and not only was their wall motion statistically improved after cell transplantation, but also their CD and MCI were statistically higher than those in the nontransplanted area. This project is adequately powered by statistical analysis. We measured CD and MCI only at one month after cell transplantation. It will be necessary to evaluate myocardial perfusion and especially cardiac function in the long term. Conclusions. We proved that bone marrow cell transplantation improved the regional perfusion in the chronic ischemic heart. Because angiogenesis after cell transplantation is the most important factor that improves myocardial condition, MCI using noninvasive MCE could be a promising tool to evaluate functional perfusion after bone marrow cell transplantation in the clinical setting.
